Recruitment

Recruitment Status
Completed
Estimated Enrollment
700

Inclusion Criterias

Subjects who have completed at least 24 months of treatment with tofacitinib in the extension study
Subjects on a stable oral dose of methotrexate (maximum dose 20 mg per week)
Subjects who have completed at least 24 months of treatment with tofacitinib in the extension study
Subjects on a stable oral dose of methotrexate (maximum dose 20 mg per week)

Summary

Conditions
Arthritis, Psoriatic
Type
Interventional
Phase
Phase 3
Design
  • Allocation: N/A
  • Intervention Model: Single Group Assignment
  • Masking: None (Open Label)
  • Masking Description: The sub-study will be participant, care provider, investigator and outcomes assessor masked.Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Inclusion Criterias

Subjects who have completed at least 24 months of treatment with tofacitinib in the extension study
Subjects on a stable oral dose of methotrexate (maximum dose 20 mg per week)
Subjects who have completed at least 24 months of treatment with tofacitinib in the extension study
Subjects on a stable oral dose of methotrexate (maximum dose 20 mg per week)

Locations

Freiburg, 79106
Grodzisk Mazowiecki, 05-825
York, YO31 8HE
Eagan, Minnesota, 55121
Fitzroy, Victoria, 3065
...
Freiburg, 79106
Grodzisk Mazowiecki, 05-825
York, YO31 8HE
Eagan, Minnesota, 55121
Fitzroy, Victoria, 3065
Southport, Queensland, 4215
Juiz de Fora, MG, 36010-570
Cleveland, Ohio, 44106
Plovdiv, 4000
Berlin, 12161
Praha 4, 140 00
Praha 2, 128 50
Yaroslavl, 150003
Elblag, 82-300
Elblag, 82-300
Bratislava, 841 04
Maroochydore, Queensland, 4558
Uherske Hradiste, 686 01
Boise, Idaho, 83702
Taichung, 40201
Boise, Idaho, 83702
Brussels, Brabant Flamand, 1070
Romford, Essex, RM7 0AG
Leuven, 3000
Curitiba, PR, 80440-080
Warszawa, 02-118
Lexington, Kentucky, 40504
Glendale, Arizona, 85306
A Coruna, 15006
Praha 2, 128 50
Merida, Yucatan, 97130
Warszawa, Mazowieckie, 01-868
Ormond Beach, Florida, 32174
Lincoln, Nebraska, 68516
Wheaton, Maryland, 20902
Guadalajara, Jalisco, 44160
Salt Lake City, Utah, 84132
Worcester, Massachusetts, 01605
Sabadell, Barcelona, 08208
Brno, 615 00
Bradford, WEST Yorkshire, BD5 0NA
Lublin, 20-582
Bialystok, 15-879
Novosibirsk, 630099
Budapest, 1062
Palm Harbour, Florida, 34684
Goodmayes, Essex, IG3 8YB
Mexico City, Distrito Federal, 06700
Brussels, 1070
Berlin, 10117
Veszprem, 8200
Duncansville, Pennsylvania, 16635
Bridgeport, Connecticut, 06606
Homburg, 66421
Lodz, 90-265
Wroclaw, 50-381
Brno, 613 00
Lublin, 20-601
Plovdiv, 4002
Porto Alegre, RS, 90035-903
Santander, Cantabria, 39008
Moscow, 119049
Chia-Yi, 62247
Dudley, WEST Midlands, DY1 2HQ
Stanford, California, 94305
Salt Lake City, Utah, 84112
Hagerstown, Maryland, 21740
San Diego, California, 92108
Genk, 3600
Salt Lake City, Utah, 84132
Waterloo, Ontario, N2J 1C4
Camberwell, Victoria, 3124
Cleveland, Ohio, 44106
Zephyrhills, Florida, 33542
Budapest, 1027
Santiago de Compostela, A Coruna, 15706
Culiacan, Sinaloa, 80000
Fitzroy, Victoria, 3065
Valencia, 46026
Brno, 63800
Tomsk, 634050
Corpus Christi, Texas, 78404
Fullerton, California, 92835
Budapest, 1062
Summerville, South Carolina, 29486
Torun, 87-100
Elblag, 82-300
Saratov, 410053
Birmingham, Alabama, 35205
Palm Desert, California, 92260
Merida, Yucatan, 97000
Taipei, 11217
Ostrava, 702 00
Yaroslavl, 150003
Jackson, Tennessee, 38305
Orlando, Florida, 32806
Poznan, 61-397
Stara Zagora, 6003
Chihuahua, 31000
Merida, Yucatan, 97000
Budapest, 1036
Berlin, 14059
Sevilla, 41010
Petrozavodsk, 185019
Chihuahua, 31000
Cypress, Texas, 77429
Gent, 9000
Bradford, WEST Yorkshire, BD96RJ
Middleburg Heights, Ohio, 44130
Budapest, 1024
Budapest, 1027
Stanford, California, 94305
Bialystok, 15-351
Bydgoszcz, 85-168
Boston, Massachusetts, 02115
Saint Louis, Missouri, 63117
Plantation, Florida, 33324
Kazan, Republic OF Tatarstan, 420103
Culiacan, Sinaloa, 80230
Mexico City, Distrito Federal, 03310
Rimavska Sobota, 979 01
Seattle, Washington, 98122
Frankfurt am Main, 60598
Bialystok, 15-002
Olsberg, 59939
Mexico City, D.F, 06700
Bad Doberan, Mecklenburg-vorp, 18209
Seattle, Washington, 98122
Martin, 03601
Upton, Wirral, CH49 5PE
Novosibirsk, 630047
Jackson, Tennessee, 38305
Culiacan, Sinaloa, 80040
Elblag, 82-300
Koeln, 50937
Seattle, Washington, 98104
Bethlehem, Pennsylvania, 18015
Huntsville, Alabama, 35801
Sevilla, 41009
Camperdown, New South Wales, 2050
Nadarzyn, 05-830
Brno, 638 00
Berlin, 10117
Merksem, 2170
Veszprem, 8200
Barcelona, 08035
Kaohsiung City, 83301
Pleven, 5800
Lebanon, New Hampshire, 03756
Warszawa, 02-691
Stanford, California, 94305
Cincinnati, Ohio, 45242
Bath, BA1 1 RL

Tracking Information

NCT #
NCT01976364
Collaborators
Not Provided
Investigators
Study Director: Pfizer CT.gov Call Center Pfizer